Pharmacokinetics 4 steps:
Absorption
Distribution
Metabolism
Excretion
Administration routes for absorption
Local
Topical: Skin, transdermal, eye, ear
Systemic:
Enteral: via intestinal tract, swallow, buccal…
TOpical: skin, rectal, inhalation
Parenteral: Via injections
Absorption – Parenteral Administration
Absorption – Enteral administration
Absorption – Bioavailability
Bioavailability (B) definition: extent to which a drug is delivered to the systemic circulation
Distribution – General body compartments
Distribution definition: Transition of a drug from the blood to the extravascular space
Distribution – Apparent volume of distribution
Theoretical volume that would be necessary to contain the total amount of administered drug atthe same concentration that it is observed in the blood plasma
Metabolism – Elimination of a compound
Removal of a substance from the body
via Exhalation, liver or kidney
Pharmacokinetics - Summary
Nano-particles and examples for requirements
Nanometer-sized spheres or capsules that can be loaded with a desired drug andallow for a controlled release in the body
Biocompatibility / non-toxicity
Ability to retain the desired compound
Ability for controlled / sustained drug release
Stability in body fluids
NP properties
Chemical
Surface funtionalization
Surface charge
Hydrophobic/-philic
Physical:
Size SHape
Surface roughness
Porosity
Effects on:
Particle aggregation
Solubility
Biodistribution
etc
Overview of possible nanocarriers
Fatty acid- and lipid-based drug NPs: Three types
NPs are formed by self assembly due to hydrophobicinteraction between their tail group
Industrial production of liposomes by ethanol injection
Industrial production of SLNP
High pressure homogenization
Hot homogenization
Cold homogenization
Inorganic NPs – Gold particles (AuNPs)
NIR absorption (650 – 1350 nm) (deep tissue penetration)
High photothermal conversion rate
Facile conjugation with functional groups (thiol-bonding
Last changed2 years ago